Selected research
Market Analysis & Forecast
Global Gut Microbiome Testing Service Market Analysis and Forecast 2026-2032
Market perspective
The global Gut Microbiome Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Gut Microbiome Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Gut Microbiome Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Gut Microbiome Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Gut Microbiome Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Gut Microbiome Testing Service include Biomesight, Carbiotix, EasyDNA, Floré Microbiome Gut Test, Genetic Analysis, GUTolution, Invivo Healthcare, Jona and Kean Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Gut Microbiome Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Gut Microbiome Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Gut Microbiome Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gut Microbiome Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gut Microbiome Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gut Microbiome Testing Service revenue, projected growth trends, production technology, application and end-user industry.
Gut Microbiome Testing Service Segment by Company
Biomesight
Carbiotix
EasyDNA
Floré Microbiome Gut Test
Genetic Analysis
GUTolution
Invivo Healthcare
Jona
Kean Health
Microba
Ombre
Randox Health
Sun Genomics
Tiny Health
Viome
Gut Microbiome Testing Service Segment by Type
Gene Sequencing-Based Testing Services
Culture-Based Testing Services
Metabolite-Based Testing Services
Gut Microbiome Testing Service Segment by Application
Health Assessment
Disease Diagnosis and Treatment
Nutrition and Health Guidance
Gut Microbiome Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gut Microbiome Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gut Microbiome Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gut Microbiome Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Gut Microbiome Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Gut Microbiome Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gut Microbiome Testing Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Sequencing-Based Testing Services
- Culture-Based Testing Services
- Metabolite-Based Testing Services
Applications
- Health Assessment
- Disease Diagnosis and Treatment
- Nutrition and Health Guidance
Companies covered
- Biomesight
- Carbiotix
- EasyDNA
- Floré Microbiome Gut Test
- Genetic Analysis
- GUTolution
- Invivo Healthcare
- Jona
- Kean Health
- Microba
- Ombre
- Randox Health
- Sun Genomics
- Tiny Health
- Viome
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Gut Microbiome Testing Service Market by Type
- 1.2.1 Global Gut Microbiome Testing Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Gene Sequencing-Based Testing Services
- 1.2.3 Culture-Based Testing Services
- 1.2.4 Metabolite-Based Testing Services
- 1.3 Gut Microbiome Testing Service Market by Application
- 1.3.1 Global Gut Microbiome Testing Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Health Assessment
- 1.3.3 Disease Diagnosis and Treatment
- 1.3.4 Nutrition and Health Guidance
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Gut Microbiome Testing Service Market Dynamics
- 2.1 Gut Microbiome Testing Service Industry Trends
- 2.2 Gut Microbiome Testing Service Industry Drivers
- 2.3 Gut Microbiome Testing Service Industry Opportunities and Challenges
- 2.4 Gut Microbiome Testing Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Gut Microbiome Testing Service Market Perspective (2021-2032)
- 3.2 Global Gut Microbiome Testing Service Growth Trends by Region
- 3.2.1 Global Gut Microbiome Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Gut Microbiome Testing Service Market Size by Region (2021-2026)
- 3.2.3 Global Gut Microbiome Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Gut Microbiome Testing Service Revenue by Players
- 4.1.1 Global Gut Microbiome Testing Service Revenue by Players (2021-2026)
- 4.1.2 Global Gut Microbiome Testing Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Gut Microbiome Testing Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Gut Microbiome Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Gut Microbiome Testing Service Key Players Headquarters & Area Served
- 4.4 Global Gut Microbiome Testing Service Players, Product Type & Application
- 4.5 Global Gut Microbiome Testing Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Gut Microbiome Testing Service Market CR5 and HHI
- 4.6.3 2025 Gut Microbiome Testing Service Tier 1, Tier 2, and Tier 3
5 Gut Microbiome Testing Service Market Size by Type
- 5.1 Global Gut Microbiome Testing Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Gut Microbiome Testing Service Revenue by Type (2021-2032)
- 5.3 Global Gut Microbiome Testing Service Revenue Market Share by Type (2021-2032)
6 Gut Microbiome Testing Service Market Size by Application
- 6.1 Global Gut Microbiome Testing Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Gut Microbiome Testing Service Revenue by Application (2021-2032)
- 6.3 Global Gut Microbiome Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Biomesight
- 7.1.1 Biomesight Company Information
- 7.1.2 Biomesight Business Overview
- 7.1.3 Biomesight Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.1.4 Biomesight Gut Microbiome Testing Service Product Portfolio
- 7.1.5 Biomesight Recent Developments
- 7.2 Carbiotix
- 7.2.1 Carbiotix Company Information
- 7.2.2 Carbiotix Business Overview
- 7.2.3 Carbiotix Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Carbiotix Gut Microbiome Testing Service Product Portfolio
- 7.2.5 Carbiotix Recent Developments
- 7.3 EasyDNA
- 7.3.1 EasyDNA Company Information
- 7.3.2 EasyDNA Business Overview
- 7.3.3 EasyDNA Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.3.4 EasyDNA Gut Microbiome Testing Service Product Portfolio
- 7.3.5 EasyDNA Recent Developments
- 7.4 Floré Microbiome Gut Test
- 7.4.1 Floré Microbiome Gut Test Company Information
- 7.4.2 Floré Microbiome Gut Test Business Overview
- 7.4.3 Floré Microbiome Gut Test Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Floré Microbiome Gut Test Gut Microbiome Testing Service Product Portfolio
- 7.4.5 Floré Microbiome Gut Test Recent Developments
- 7.5 Genetic Analysis
- 7.5.1 Genetic Analysis Company Information
- 7.5.2 Genetic Analysis Business Overview
- 7.5.3 Genetic Analysis Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Genetic Analysis Gut Microbiome Testing Service Product Portfolio
- 7.5.5 Genetic Analysis Recent Developments
- 7.6 GUTolution
- 7.6.1 GUTolution Company Information
- 7.6.2 GUTolution Business Overview
- 7.6.3 GUTolution Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.6.4 GUTolution Gut Microbiome Testing Service Product Portfolio
- 7.6.5 GUTolution Recent Developments
- 7.7 Invivo Healthcare
- 7.7.1 Invivo Healthcare Company Information
- 7.7.2 Invivo Healthcare Business Overview
- 7.7.3 Invivo Healthcare Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Invivo Healthcare Gut Microbiome Testing Service Product Portfolio
- 7.7.5 Invivo Healthcare Recent Developments
- 7.8 Jona
- 7.8.1 Jona Company Information
- 7.8.2 Jona Business Overview
- 7.8.3 Jona Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Jona Gut Microbiome Testing Service Product Portfolio
- 7.8.5 Jona Recent Developments
- 7.9 Kean Health
- 7.9.1 Kean Health Company Information
- 7.9.2 Kean Health Business Overview
- 7.9.3 Kean Health Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Kean Health Gut Microbiome Testing Service Product Portfolio
- 7.9.5 Kean Health Recent Developments
- 7.10 Microba
- 7.10.1 Microba Company Information
- 7.10.2 Microba Business Overview
- 7.10.3 Microba Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Microba Gut Microbiome Testing Service Product Portfolio
- 7.10.5 Microba Recent Developments
- 7.11 Ombre
- 7.11.1 Ombre Company Information
- 7.11.2 Ombre Business Overview
- 7.11.3 Ombre Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Ombre Gut Microbiome Testing Service Product Portfolio
- 7.11.5 Ombre Recent Developments
- 7.12 Randox Health
- 7.12.1 Randox Health Company Information
- 7.12.2 Randox Health Business Overview
- 7.12.3 Randox Health Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Randox Health Gut Microbiome Testing Service Product Portfolio
- 7.12.5 Randox Health Recent Developments
- 7.13 Sun Genomics
- 7.13.1 Sun Genomics Company Information
- 7.13.2 Sun Genomics Business Overview
- 7.13.3 Sun Genomics Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Sun Genomics Gut Microbiome Testing Service Product Portfolio
- 7.13.5 Sun Genomics Recent Developments
- 7.14 Tiny Health
- 7.14.1 Tiny Health Company Information
- 7.14.2 Tiny Health Business Overview
- 7.14.3 Tiny Health Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Tiny Health Gut Microbiome Testing Service Product Portfolio
- 7.14.5 Tiny Health Recent Developments
- 7.15 Viome
- 7.15.1 Viome Company Information
- 7.15.2 Viome Business Overview
- 7.15.3 Viome Gut Microbiome Testing Service Revenue and Gross Margin (2021-2026)
- 7.15.4 Viome Gut Microbiome Testing Service Product Portfolio
- 7.15.5 Viome Recent Developments
8 North America
- 8.1 North America Gut Microbiome Testing Service Revenue (2021-2032)
- 8.2 North America Gut Microbiome Testing Service Revenue by Type (2021-2032)
- 8.2.1 North America Gut Microbiome Testing Service Revenue by Type (2021-2026)
- 8.2.2 North America Gut Microbiome Testing Service Revenue by Type (2027-2032)
- 8.3 North America Gut Microbiome Testing Service Revenue Share by Type (2021-2032)
- 8.4 North America Gut Microbiome Testing Service Revenue by Application (2021-2032)
- 8.4.1 North America Gut Microbiome Testing Service Revenue by Application (2021-2026)
- 8.4.2 North America Gut Microbiome Testing Service Revenue by Application (2027-2032)
- 8.5 North America Gut Microbiome Testing Service Revenue Share by Application (2021-2032)
- 8.6 North America Gut Microbiome Testing Service Revenue by Country
- 8.6.1 North America Gut Microbiome Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Gut Microbiome Testing Service Revenue by Country (2021-2026)
- 8.6.3 North America Gut Microbiome Testing Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Gut Microbiome Testing Service Revenue (2021-2032)
- 9.2 Europe Gut Microbiome Testing Service Revenue by Type (2021-2032)
- 9.2.1 Europe Gut Microbiome Testing Service Revenue by Type (2021-2026)
- 9.2.2 Europe Gut Microbiome Testing Service Revenue by Type (2027-2032)
- 9.3 Europe Gut Microbiome Testing Service Revenue Share by Type (2021-2032)
- 9.4 Europe Gut Microbiome Testing Service Revenue by Application (2021-2032)
- 9.4.1 Europe Gut Microbiome Testing Service Revenue by Application (2021-2026)
- 9.4.2 Europe Gut Microbiome Testing Service Revenue by Application (2027-2032)
- 9.5 Europe Gut Microbiome Testing Service Revenue Share by Application (2021-2032)
- 9.6 Europe Gut Microbiome Testing Service Revenue by Country
- 9.6.1 Europe Gut Microbiome Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Gut Microbiome Testing Service Revenue by Country (2021-2026)
- 9.6.3 Europe Gut Microbiome Testing Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Gut Microbiome Testing Service Revenue (2021-2032)
- 10.2 China Gut Microbiome Testing Service Revenue by Type (2021-2032)
- 10.2.1 China Gut Microbiome Testing Service Revenue by Type (2021-2026)
- 10.2.2 China Gut Microbiome Testing Service Revenue by Type (2027-2032)
- 10.3 China Gut Microbiome Testing Service Revenue Share by Type (2021-2032)
- 10.4 China Gut Microbiome Testing Service Revenue by Application (2021-2032)
- 10.4.1 China Gut Microbiome Testing Service Revenue by Application (2021-2026)
- 10.4.2 China Gut Microbiome Testing Service Revenue by Application (2027-2032)
- 10.5 China Gut Microbiome Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Gut Microbiome Testing Service Revenue (2021-2032)
- 11.2 Asia Gut Microbiome Testing Service Revenue by Type (2021-2032)
- 11.2.1 Asia Gut Microbiome Testing Service Revenue by Type (2021-2026)
- 11.2.2 Asia Gut Microbiome Testing Service Revenue by Type (2027-2032)
- 11.3 Asia Gut Microbiome Testing Service Revenue Share by Type (2021-2032)
- 11.4 Asia Gut Microbiome Testing Service Revenue by Application (2021-2032)
- 11.4.1 Asia Gut Microbiome Testing Service Revenue by Application (2021-2026)
- 11.4.2 Asia Gut Microbiome Testing Service Revenue by Application (2027-2032)
- 11.5 Asia Gut Microbiome Testing Service Revenue Share by Application (2021-2032)
- 11.6 Asia Gut Microbiome Testing Service Revenue by Country
- 11.6.1 Asia Gut Microbiome Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Gut Microbiome Testing Service Revenue by Country (2021-2026)
- 11.6.3 Asia Gut Microbiome Testing Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Gut Microbiome Testing Service Revenue (2021-2032)
- 12.2 SAMEA Gut Microbiome Testing Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Gut Microbiome Testing Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Gut Microbiome Testing Service Revenue by Type (2027-2032)
- 12.3 SAMEA Gut Microbiome Testing Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Gut Microbiome Testing Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Gut Microbiome Testing Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Gut Microbiome Testing Service Revenue by Application (2027-2032)
- 12.5 SAMEA Gut Microbiome Testing Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Gut Microbiome Testing Service Revenue by Country
- 12.6.1 SAMEA Gut Microbiome Testing Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Gut Microbiome Testing Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Gut Microbiome Testing Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst